Maʻi bronchitis. Lapaau i ka exacerbation a me ke kala ana i kahua o ka hoʻonaʻauao

Ke mainstay o ka hana maikaʻiʻole o ka maʻi bronchitis o ka hoʻopau o ka etiological maʻi ololi. Inā diagnosed me ka maʻi bronchitis, lapaʻau pono uiki cessation, loa o keʻenaʻoihana ÷ ino, sanitation foci o ka maʻiʻaʻai. Inpatient lapaʻau o ka maʻi bronchitis i loko o nā mākua a me ka moe koena ua hoakaka ia no ka huʻi maʻi me ka hoomahuahua i loko o naehana hanu a me ka naau e hemahema, symptoms o intoxication, e pili ana i huʻi pneumonia a noho'na makaainana i ulu pneumothorax, ina he pono, ke kauoha o ka lapaʻau 'ana a me ka pākōlea kaʻina hana. Lapaʻau no kou kino e e puleʻAmelika, kumuʻiʻo-wikamina, ma ka hihia o ka hui ana decompensated cardiac pulmonary kali papaaina paakai, a me ka wai a me ka ulu potasiuma maʻiʻo.

All hana i kumu lāʻau Inc E e kauoha ana i ka iapaau ana o ke iaʻi. Ka paʻa, ma hope Inc bronchial patency pāʻani i ka nui kūlana ma ke kiʻekiʻe-mahele lāʻau anticholinergic. Inā loaʻa trapevticheskogo hookoia no, ka mea hiki ke lawelawe i loko o ka palapala o ka lōʻihi-makahiki monotherapy. Me iki hookoia, e nui ana ke hooloihi Hoʻokolohua-agonists o pōkole hana. Kekahi nā mea maʻi i manaoia e ia i ka loa ka hoʻokō pu ana o ka ai 'i loaʻa ka anticholinergic a me ka Hoʻokolohua-agonist. Anticholinergics a me Hoʻokolohua-agonists i hoakaka ia ana.

Me ka hou Holomua o ka maʻi i loko o ka 'inikua pakuhi i hoʻohuiʻia methylxanthines, i a me kā lākou bronchodilator hana emi luhi o ka ÷ naehana hanu nāʻiʻo, akā, e oiʻawahia, noi aku ka mālamaʻana o ka lāʻau lapaʻau lehulehu.

I kekahi kahua o ka lōʻihi-makahiki iapaau ana o ka maʻi bronchitis i ia i ka hookohu o ka glucocorticosteroids. ua haawiia mai ia ana pepa koho. Ka hoʻokohu 'koi' ia systemic corticosteroids wale i ka huʻi maʻi.

I a hiki i ka lapaʻau ia no ekolu i eha pule, a ua hookupaa iho la ia ma ka oleloʻano o ka akemāmā hoʻokomo ea kuleana pili i, ka mea, ua pono i ka gradual ka ho'ēmiʻana i ka mahele lāʻau ano o ka hoʻololi i ka ana glucocorticosteroid.

An nui ololi i loko o ka hoʻomaikaʻi bronchial iaʻi o ka hoihoi hou ana o maʻamau surfactant'ōnaehana e pono maʻi obstructive bronchitis. Lapaʻau ua lawe mai a mucolytics mukoregulyatorami hoonoho ma ka inhalation, hōʻike waha a me ka parenterally. Ka loa ka hoʻokō ai 'ma keia pae i ambroxol a me ka acetylcysteine.

Maʻi bronchitis lapaau i loko o ka huʻi pae o infectious kumu pono antibiotics. Advantageously hoakaka semisynthetic macrolides a me ampicillin. I ka papa o antibiotics hoakaka ia no kekahi i mau pule. Ma waho aʻeo ia ka lapaʻauʻia, ua pono 'ē aʻe therapies e lanakila maʻi bronchitis. Iapaau ana ua lawe mai pākahi wae hanu kino,ʻai hookohu e normalize kino ke kaumaha.

I loko nō o ka mea i maʻi bronchitis - he e holumua ai maʻi, pono wae a me ka 'eleu hana hiki' ūlōlohi mai ana i ka hooulu ana o bronchial iaʻi, pale aku i ka ulu ana o complications, a hoʻoikaika ka pono o ke ola o nā mea maʻi.

Hoʻoikaika 'ana i ka papa nōkahea o bronchi kāʻia e ka lanakila umauma lomilomi, lāʻau lapaʻau lāʻau lapaʻau, postural nōkahea. Detoxification Inc ua pono ina ano hoomainoino ma suppurative maʻi bronchitis. Lapaʻau e e he OAXA hoʻi o antibacterial Inc.

Ka wā e hoomanawanui i loaʻa ke kala ana i loko o ka hapa nui o ka hoopii i ke hoʻomau lapaau. Nā mea maʻi me ka obstructive bronchitis ma ke kala ana i dispense me ka ai '. Nā mea maʻi me ka obstructive bronchitis ua kokoke mau mea, hoʻoikaika ihola e lawe broncho-spasmolytic a me ka expectorant.